DRUG

teneligliptin

1 hypothesis across 1 therapeutic domain

ALL HYPOTHESES

Repurposing candidates for teneligliptin

Inflammatory bowel disease 1

Mediator Outcome Score Tier Lit. status Trial
DPP-4 disease activity 0.220 Mid novel signal completed

Clinical trials

33 registered trials for teneligliptin

Source: ClinicalTrials.gov

← All drugs